<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350251</id>
  <title nil="true"/>
  <common-name>N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[2-[(e)-2-(2-hydroxyphenyl)ethenyl]-4-oxoquinazolin-3-yl]benzenecarboximidamide</common-name>
  <description>N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[2-[(e)-2-(2-hydroxyphenyl)ethenyl]-4-oxoquinazolin-3-yl]benzenecarboximidamide is a chemical compound with the formula C30H23N7O3. With an average molecular weight of 529.50 g/mol, N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[2-[(e)-2-(2-hydroxyphenyl)ethenyl]-4-oxoquinazolin-3-yl]benzenecarboximidamide is a heavy molecule.</description>
  <cas>127786-23-6</cas>
  <pubchem-id>135568446</pubchem-id>
  <chemical-formula>C30H23N7O3</chemical-formula>
  <weight>529.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:12:32Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:12:32Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)C(=NN2C(=NC3=CC=CC=C3C2=O)C=CC4=CC=CC=C4O)N=NC5=CC=C(C=C5)C(=O)NN</moldb-smiles>
  <moldb-formula>C30H23N7O3</moldb-formula>
  <moldb-inchi>InChI=1S/C30H23N7O3/c31-33-29(39)22-14-17-23(18-15-22)34-35-28(21-9-2-1-3-10-21)36-37-27(19-16-20-8-4-7-13-26(20)38)32-25-12-6-5-11-24(25)30(37)40/h1-19,38H,31H2,(H,33,39)/b19-16+,35-34?,36-28-</moldb-inchi>
  <moldb-inchikey>RHIIJSDLDDIQSA-VWQZQYQMSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">529.1862376</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346144</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[4-(hydrazinecarbonyl)phenyl]imino-n'-[2-[(e)-2-(2-hydroxyphenyl)ethenyl]-4-oxoquinazolin-3-yl]benzenecarboximidamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom nil="true"/>
  <superklass nil="true"/>
  <klass nil="true"/>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300558</sync-id>
  <structure-inchikey>RHIIJSDLDDIQSA-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>8000001000000400000000000000002000000000000000000000400000200000000000000020040000000000004000000000020000800050000080000000000000000000000000200000000002000000040040000000000004001100000010000000000000000000000011000000400000000000000002000000000000008040000008000000800010000001000000000000000208000000000000000000000400000848000000000000000000000000000000000010200000000401000021800000000000084000000044000000200002000000000020000000010000030000c0000000000400000000000000005000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAoAAAALAAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:14Z</structure-indexed-at>
</compound>
